Dominari Holdings Inc. (DOMH)

Market Cap	16.02M
Revenue (ttm)	2.04M
Net Income (ttm)	-22.88M
Shares Out	5.93M
EPS (ttm)	-4.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,444
Open	2.700
Previous Close	2.790
Day's Range	2.700 - 2.810
52-Week Range	1.760 - 3.670
Beta	0.94
Analysts	n/a
Price Target	n/a
Earnings Date	May 9, 2024

About DOMH

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebol...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1967
• Employees: 26
• Stock Exchange: NASDAQ
• Ticker Symbol: DOMH